Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277993
Max Phase: Preclinical
Molecular Formula: C16H13Cl2N3
Molecular Weight: 318.21
Associated Items:
ID: ALA5277993
Max Phase: Preclinical
Molecular Formula: C16H13Cl2N3
Molecular Weight: 318.21
Associated Items:
Canonical SMILES: CNc1ccc2cc(-c3cc(Cl)cc(Cl)c3)c(N)nc2c1
Standard InChI: InChI=1S/C16H13Cl2N3/c1-20-13-3-2-9-6-14(16(19)21-15(9)8-13)10-4-11(17)7-12(18)5-10/h2-8,20H,1H3,(H2,19,21)
Standard InChI Key: OHHFZVKAHHKVNI-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 318.21 | Molecular Weight (Monoisotopic): 317.0487 | AlogP: 4.83 | #Rotatable Bonds: 2 |
Polar Surface Area: 50.94 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.73 | CX LogP: 4.22 | CX LogD: 3.74 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.71 | Np Likeness Score: -0.87 |
1. Hammill JT, Sviripa VM, Kril LM, Ortiz D, Fargo CM, Kim HS, Chen Y, Rector J, Rice AL, Domagalska MA, Begley KL, Liu C, Rangnekar VM, Dujardin JC, Watt DS, Landfear SM, Guy RK.. (2021) Amino-Substituted 3-Aryl- and 3-Heteroarylquinolines as Potential Antileishmanial Agents., 64 (16.0): [PMID:34355566] [10.1021/acs.jmedchem.1c00813] |
Source(1):